Angela Hassman

Angela Hassman is a seasoned clinical research leader with over 2 decades of experience in early-phase clinical trial operations.

Dr Jim Bush

Dr. Jim Bush, Vice President Medical Services, Clinical Pharmacology and Principal Investigator. Dr.

A patient-centric approach to advance respiratory drug development

Targeting the heart of the problem: why coronary inflammation is cardiovascular medicine's next frontier

Three key insights from NeuPSIG 2025 that are reshaping chronic pain research

Smarter, faster, better: How AI is reshaping neuroscience clinical trials

How can neuroscience clinical trial sponsors use AI to reduce complexity, accelerate timelines and lower costs in a high-risk, delay-prone research environment?

Cortex Conversations: Insights in Neuroscience

Choosing the right AI vendor for clinical trials in a rapidly evolving landscape

Choosing the right AI vendor can transform your clinical trial strategy. Explore key questions to shape effective, future-ready collaborations.

AI can find the patients-but can humans reach them?

If AI can rapidly identify eligible patients for ophthalmology clinical trials, what strategies must sponsors, CROs and research sites adopt to overcome human and operational barriers and full realize AI's potential in patient recruitment?